LOGIN
ID
PW
MemberShip
2025-07-02 14:59
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Product
'Govn¡¯t must take strong action against pharma rebates'
by
Kang, Hye-Kyung
Jun 26, 2025 06:08am
The Korean Pharmacists for Democratic Society (President Gyeong-rim Jeon, KPDS) has urged the government to take strong action against pharmaceutical company rebates. KPDS issued a statement regarding rebates made by a major domestic pharmaceutical company that JTBC reported. In the statement, KPDS said, ¡°This is not an individual incide
Product
Patient organization proposes 6 policies as election pledges
by
Kang, Hye-Kyung
May 14, 2025 06:10am
A patient group has proposed six policies, including a ¡°rapid reimbursement for new drugs and post-marketing adjustment system.¡± The Korea Alliance of Patients Organization submitted a 'Statement regarding Six Major Patient Policies' to political parties on the first day of the official campaign for the 21st presidential election on the
Product
Indiscriminate in-hospital prescriptions of Wegovy
by
Jung, Heung-Jun
May 13, 2025 06:06am
Criticism arose regarding the indiscriminate in-hospital prescriptions of Wegovy, which is currently allowed with an exception. According to the Korean Pharmaceutical Affairs Act, in-hospital prescription is allowed only when an 'injectable is injected.' However, it has been pointed out that Wegovy is being sold without a single act of inj
Product
Paxlovid transition to general health system effective June
by
Apr 11, 2025 06:01am
Paxlovid, a treatment for COVID-19, will be transitioned to the general healthcare system starting in June. The free supply previously provided to centers designated for COVID-19 treatment (prescribing facilities) will be terminated entirely due to stock depletion. According to local pharmacists, on the 9th, various local public health
Product
Distributors of Neurontin, Lyrica, and Celebrex to change
by
Kim JiEun
Feb 14, 2025 05:58am
With the transfer of sales rights between domestic pharmaceutical companies for major original products expected, the change is expected to affect not only the pharmaceutical and distribution industries but also front-line pharmacies. According to the pharmaceutical wholesale industry sources on the 13th, the transfer of rights to domes
Product
Non-face-to-face treatment takes another hit
by
Jung, Heung-Jun
Feb 12, 2025 06:13am
Following the restriction of Wegovy prescriptions through non-face-to-face medical care, voices are rising on the need to regulate the prescription of artificial tears as well. The platform industry believes that overprescription is an issue that occurs regardless of whether the patient receives face-to-face or non-face-to-face care. The
Product
Wegovy outpatient prescriptions ¡é¡¦pharmacy burden¡è
by
Jung, Heung-Jun
Feb 12, 2025 06:13am
Wegovy, whose sales suffered due to inventory shortage in pharmacies, has now become an intractable inventory four months after its launch in Korea. Wegovy is a self-injectable drug that requires refrigeration and is a non-returnable product. Each unit costs tens of thousands of won, so pharmacies bear a heavy burden if it becomes a dead
Product
Will doctor-pharmacist conflict reignite?
by
Kim JiEun
Jan 7, 2025 06:05am
With candidate Joo Soo-ho, who advocates for the selective dispensing of drugs, advancing to the runoff election for the new president of the Korean Medical Association, a potential conflict between the medical community and the pharmaceutical association is expected. In the 43rd presidential election of the Korean Medical Association, wh
Product
Price of Pulmican, Pulmicort, Tantum Sol to be raised in Jan
by
Kang Hye-Kyung
Dec 27, 2024 05:56am
As of January 1 next year, items including Pulmican, Pulmicort, and Tantum Sol which are set to receive price hikes, will demand the pharmacists' attention. According to a notice from the Ministry of Health and Welfare on the 24th, the price of ¡ã Whanin Imipramine HCl Tab 25mg ¡ã Lithan Tab ¡ã Myungin Lithium Carbonate Tab ¡ã Myungin Lithium
Product
Gout drug allopurinol side effect alert
by
Kang, Shin-Kook
Nov 20, 2024 06:08am
As reports of adverse reactions to allopurinol, a drug prescribed for gout, continue to mount, health authorities are calling for genetic testing of patients before prescribing it to prevent side effects. According to medical and pharmaceutical associations on the 19th, the NMC Adverse Drug Reaction&160;Committee recently reviewed applicatio
1
2
3
4
5
6
7
8
9
10
>